DCOY MEXC RealStocks
Own real DCOY shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 13:28:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Decoy Therapeutics Inc. (DCOY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.08, with a market capitalization of $727.26K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.90 to $16.92. This page covers its latest market performance, valuation, price trends and company information.
$727.26K | |
$1.09 | |
$1.09 | |
$1.02 | |
$1.09 | |
1.01K | |
2.20M | |
-- | |
$16.92 | |
$0.90 | |
-- | |
-- |
Decoy Therapeutics Inc. (DCOY) is trading at $1.08 in pre-market trading as of 2026-11-12 13:23:00, down 0.92% ($0.01) from the previous close of $1.09
Pre-market trading shows how investors are pricing DCOY before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Decoy Therapeutics Inc. (DCOY) moved from $1.11 to $1.08, representing a decline of 2.70% ($0.03).
The stock traded between $0.99 and $1.15 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 39.11 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1.1%
DCOY is currently trading at $1.08, placing it 1.1% of the way from its 52-week low of $0.90 to its 52-week high of $16.92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Decoy Therapeutics Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Decoy Therapeutics Inc. (DCOY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to DCOY, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between DCOY shares and USD.
DCOY Shares to USD
1.00 DCOY shares = 1.08 USD
Calculations are estimates based on the latest available price and are for reference only.